Literature DB >> 5458217

Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in man.

S R Mostow, S C Schoenbaum, W R Dowdle, M T Coleman, H S Kaye, J C Hierholzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5458217     DOI： 10.1093/oxfordjournals.aje.a121204

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  15 in total

1.  Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company.

Authors:  E Burckel; T Ashraf; J P de Sousa Filho; E Forleo Neto; H Guarino; C Yauti; B Barreto F de; L Champion
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

Review 2.  Novel vaccines against influenza viruses.

Authors:  S M Kang; J M Song; R W Compans
Journal:  Virus Res       Date:  2011-10-01       Impact factor: 3.303

3.  Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.

Authors:  Robert B Couch; Patricia Winokur; Rebecca Brady; Robert Belshe; Wilbur H Chen; Thomas R Cate; Bryndis Sigurdardottir; Amy Hoeper; Irene L Graham; Robert Edelman; Fenhua He; Diane Nino; Jose Capellan; Frederick L Ruben
Journal:  Vaccine       Date:  2007-09-14       Impact factor: 3.641

4.  Influenza immunization: serologic and clinical responses in military units.

Authors:  N Egoz; B Morag; W Klingberg; R Chen; M A Klingberg
Journal:  Infection       Date:  1977       Impact factor: 3.553

5.  Swine influenza vaccine program in the community: acceptability, reactions and responses.

Authors:  A S Monto; H W Ross
Journal:  Am J Public Health       Date:  1979-03       Impact factor: 9.308

6.  Detection of site-specific positive Darwinian selection on pandemic influenza A/H1N1 virus genome: integrative approaches.

Authors:  Ramaiah Arunachalam
Journal:  Genetica       Date:  2013-03-26       Impact factor: 1.082

7.  Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly.

Authors:  W A Keitel; T R Cate; R L Atmar; C S Turner; D Nino; C M Dukes; H R Six; R B Couch
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

8.  Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.

Authors:  M L Clements; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

9.  Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation.

Authors:  S R Mostow; S C Schoenbaum; W R Dowdle; M T Coleman; H S Kaye
Journal:  Postgrad Med J       Date:  1973-03       Impact factor: 2.401

10.  Humoral and secretory antibody responses to immunization with low and high dosage split influenza virus vaccine.

Authors:  F L Ruben; C W Potter; C H Stuart-Harris
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.